Page 4 - Medicines

Zydus Lifesciences gets final FDA nod for Darunavir for HIV-1 treatment

According to market research firm IQVIA, Darunavir Tablets, 75 mg, 150 mg, 600 mg, and 800 mg had annual sales of $275 million in the US

Loss of patents: Indian pharma companies gain, shows PharmaTrac data

While MNCs posted a 5 per cent five-year compound annual growth rate (CAGR) in the chronic segment, Indian pharma companies have recorded a 9 per cent 5-year CAGR

Mefenamic acid can have adverse reactions; govt issues drug safety alert

The Indian Pharmacopoeia Commission (IPC) states that painkiller Meftal can cause adverse reactions, including drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome

Painkiller Meftal can trigger adverse reactions!

Alert! Painkiller Meftal could cause DRESS syndrome. Watch the video to know how this drug can be effective but risky. >

Maldives reports contamination in Pakistani syrups, suspension medicines

The report prompted the World Health Organisation to issue an alert urging countries to step up vigilance and test products manufactured by a Lahore-based pharmaceutical company, according to Dawn

Indian pharma industry can grow to $450 bn by 2047: EY-OPPI report

The report underlines the need for collaboration and alignment between the industry, academia and government to advance research and innovation capabilities

Medicines for four rare diseases become cheaper due to domestic production

Medicines for four rare diseases have become available at drastically cheaper rates as Indian pharma companies are now producing them reducing the reliance on expensive imported formulations, Union Health Ministry officials said on Friday. The slashing of prices comes as the ministry has prioritised action related to 13 rare diseases along with sickle cell anaemia. Drugs for four of these diseases -Tyrosinemia Type 1, Gaucher's Disease, Wilson's Disease and Dravet-Lennox Gastaut Syndrome - along with sickle cell Anemia have been approved and are being manufactured indigenously. Four more drugs for three diseases - Tablet Sapropterin for Phenylketonuria, tab Sodium Phenyl Butyrate and tablet Carglumic Acid for Hyperammonemia and Capsule Miglustat for Gaucher's disease - are under process for approval and are likely to be available by April 2024, official sources said. With these drugs being manufactured indigenously, the annual cost of Nitisinone capsules, used in the treatment of .

SC cautions Patanjali over making 'false' claims about its medicines in ads

The Supreme Court Tuesday cautioned Patanjali Ayurved, a company co-founded by yoga guru Ramdev and dealing in herbal products, against making "false" and "misleading" claims in advertisements about its medicines as cure of several diseases. "All such false and misleading advertisements of Patanjali Ayurved have to stop immediately. The court will take any such infraction very seriously...," a bench comprising justices Ahsanuddin Amanullah and Prashant Kumar Mishra orally observed while hearing a plea of the Indian Medical Association (IMA). The top court, on August 23, 2022, had issued notices to the Union health ministry and Ministry of Ayush and Patanjali Ayurved Ltd, on the plea of the IMA alleging a smear campaign by Ramdev against the vaccination drive and modern medicines. During the brief hearing, the bench asked Patanjali Ayurved not to publish misleading claims and advertisements against modern systems of medicine. It said the bench may also consider imposing a fine of Rs

Strides Pharma arm obtains USFDA nod for Levetiracetam oral solution

According to market research firm IQVIA, the Levetiracetam oral solution has a market size of $55 million

Pharma majors turn attention to OTC drugs in post-pandemic wellness shift

Building a healthy OTC brand, however, is not an easy task. OTC brands need time to grow and build a recall value once they have established some credibility

Biocon biologics receives marketing approval by MHRA for YESAFILI in UK

This approval follows the green light granted by the European Commission (EC) for marketing authorisation in the European Union (EU) back in September

India, Netherlands to cooperate on regulations for medical products

India and the Netherlands will cooperate on regulations for medical products and enhance the quality of healthcare services in both countries. At Hague, India and the Netherlands have "signed a memorandum of intent (MoI) to cooperate on medical product regulation and enhance the quality of medical products and healthcare services for both countries". The MoI was signed during a meeting of Bhagwant Khuba, Union Minister of State for Chemicals and Fertilizers with Ernst Kuipers Minister of Health, Welfare and Sports of the Kingdom of Netherlands. An Indian delegation led by Khuba is in the Netherlands to participate in the second World Local Production Forum (WLPF) meeting being held in The Hague from 6 to 8 November 2023. The World Local Production Platform is a platform created at the initiative of WHO with the aim of increasing access to medicines and other health technologies. The Minister also visited the European Medicines Agency (EMA). He met Carla van Rooijen, Director of t

IIT Guwahati discovers modified graphene oxide's potential in medicine

Researchers at the Indian Institute of Technology (IIT) Guwahati have developed cost-effective experiments for modifying graphene oxide that can be used by other academic institutions to train personnel needed for cutting-edge projects in semiconductors, nanoelectronics, healthcare and quantum technologies. A team led by Rajiv K Kar, assistant professor, at the Jyoti and Bhupat Mehta School of Health Sciences and Technology in IIT-Guwahati, have made these important discoveries regarding the use of modified graphene oxide for biomedical applications, a release said on Tuesday. Graphene is an exceptionally strong material and possesses outstanding electrical and thermal conductivity. Its oxidised form, called Graphene Oxide (GO), offers a large surface area and low cytotoxicity, making it suitable for medical applications. GO can be further engineered through defects, doping and functional modifications, which enhance its optical and electrical properties for improved biomedical ...

Rectitude question for a Nobel winner

Science deals with measurements to micro-levels of accuracy and sophisticated statistical methods are employed to tease signals out of noise

Indian envoy to Myanmar proposes setting up JWG for Traditional Medicine

Thein Zaw Linn, Rector, faculty members and students of UTM, Mandalay were informed about Ayush scholarships and Fellowships available in India

Lupin receives tentative approval from US FDA for apalutamide tablets

Lupin develops and commercialises a wide range of branded and generic formulations, biotechnology products, and Active Pharmaceutical Ingredients (APIs) in over 100 markets

PM Janaushadhi Kendras-like stores for animal medicines on the cards

The Janaushadhi Kendras are a collaboration between government agencies and private entrepreneurs

Experts not in favour of nicotine replacement therapy as prescription drug

Nicotine replacement therapies are safe and empower individuals to quit smoking, a group of doctors have said while expressing concern over the proposal to reclassify them as prescription drugs. Experts feel the move to reclassify them as prescription drugs will limit their accessibility to those seeking to stop tobacco consumption. The Drugs Technical Advisory Board (DTAB) under the Central Drugs Standard Control Organisation (CDSCO) has proposed to place nicotine replacement therapies under Schedule K of the Drugs and Cosmetics Rules so that in future they would be available only on the prescription of authorised medical practitioners and not as over-the-counter preparation. Nicotine polacrilex gums, lozenges and transdermal patches are used for nicotine replacement therapies (NRT). NRT offers a 50 per cent higher probability of quitting smoking compared to attempting to quit without it, and it is both safe and readily available without the need for a prescription, experts have .

Nobel Prize 2023 in Medicine awarded to Katalin Kariko, Drew Weissman

The 2022 Nobel Prize in Physiology or Medicine was awarded to Swedish geneticist Svante Paab

Triple jeopardy in health

This is not all. Not only are we not conserving the existing stock of medicines, the drug pipeline for new antibiotics is drying up, or has done so already